Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Get To Be familiar with The Historical backdrop Of Western Medication- Vote In favor of Your Favored Cereal
- Partner of crime boss Steven Lyons arrested in Dubai
- Tracking down the Right Equilibrium: Charges versus Personal Costs in Senior Protection.
- Overseeing Individual budgets Successfully
- Grasping Various Kinds of Local misdemeanors
- A Texas GOP congressman is retiring. Trump just endorsed his identical twin to replace him.
- Artemis II astronauts race to set a new distance record from Earth and behold the moon's far side
- Figure out How to Assess the Unwavering quality of SUVs for Seniors
